Jason Mills

Stock Analyst at Canaccord Genuity

(3.92)
# 668
Out of 4,761 analysts
118
Total ratings
70.1%
Success rate
35.28%
Average return

Stocks Rated by Jason Mills

Penumbra
Feb 19, 2025
Maintains: Buy
Price Target: $323$340
Current: $291.68
Upside: +16.57%
TransMedics Group
Oct 29, 2024
Maintains: Buy
Price Target: $169$109
Current: $71.95
Upside: +51.49%
STAAR Surgical Company
Apr 26, 2022
Maintains: Buy
Price Target: $81$89
Current: $16.87
Upside: +427.56%
AngioDynamics
Jul 14, 2021
Maintains: Hold
Price Target: $24$28
Current: $10.33
Upside: +171.06%
iRhythm Technologies
Nov 6, 2020
Maintains: Buy
Price Target: $236$273
Current: $119.44
Upside: +128.57%
Merit Medical Systems
Oct 29, 2020
Maintains: Buy
Price Target: $51$55
Current: $103.16
Upside: -46.68%
Neuronetics
Oct 26, 2020
Maintains: Buy
Price Target: $4$8
Current: $4.13
Upside: +93.70%
Nevro
Aug 6, 2020
Maintains: Buy
Price Target: $116$153
Current: $5.73
Upside: +2,570.16%
LeMaitre Vascular
Jul 24, 2020
Maintains: Hold
Price Target: $28$30
Current: $99.54
Upside: -69.86%
Intuitive Surgical
Jul 22, 2020
Maintains: Buy
Price Target: $187$242
Current: $591.79
Upside: -59.16%
Maintains: Hold
Price Target: $66$50
Current: $47.44
Upside: +5.40%
Maintains: Buy
Price Target: $41$45
Current: $38.39
Upside: +17.22%
Maintains: Buy
Price Target: $85$62
Current: $15.05
Upside: +311.96%
Maintains: Buy
Price Target: $43$46
Current: $104.49
Upside: -55.98%
Upgrades: Buy
Price Target: n/a
Current: $80.28
Upside: -